0001213900-24-018675.txt : 20240229
0001213900-24-018675.hdr.sgml : 20240229
20240229195632
ACCESSION NUMBER: 0001213900-24-018675
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240227
FILED AS OF DATE: 20240229
DATE AS OF CHANGE: 20240229
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Santos da Silva Jorge
CENTRAL INDEX KEY: 0001920509
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39630
FILM NUMBER: 24706362
MAIL ADDRESS:
STREET 1: DORFSTRASSE 29
CITY: ZUG
STATE: V8
ZIP: 6300
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MoonLake Immunotherapeutics
CENTRAL INDEX KEY: 0001821586
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: DORFSTRASSE 29
CITY: ZUG
STATE: V8
ZIP: 6300
BUSINESS PHONE: 41 41 510 8022
MAIL ADDRESS:
STREET 1: DORFSTRASSE 29
CITY: ZUG
STATE: V8
ZIP: 6300
FORMER COMPANY:
FORMER CONFORMED NAME: Helix Acquisition Corp
DATE OF NAME CHANGE: 20200818
4
1
ownership.xml
X0508
4
2024-02-27
0
0001821586
MoonLake Immunotherapeutics
MLTX
0001920509
Santos da Silva Jorge
C/O MOONLAKE IMMUNOTHERAPEUTICS
DORFSTRASSE 29
ZUG
V8
6300
SWITZERLAND
1
1
0
0
Chief Executive Officer
1
Class A ordinary shares, par value $0.0001 per share
2024-02-27
4
S
0
62810
55.00
D
3043619
D
Class A ordinary shares, par value $0.0001 per share
2024-02-28
4
S
0
56065
55.00
D
2987554
D
Class A ordinary shares, par value $0.0001 per share
2024-02-29
4
S
0
4740
55.89
D
2982814
D
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on October 17, 2023.
The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $55.50 to $57.55. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
/s/ Matthias Bodenstedt, Attorney-in-fact for Jorge Santos da Silva
2024-02-29